drugset / Trial / NCT07509892
A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To assess the efficacy and safety of TQH3906 in treating systemic lupus erythematosus.
Timeline
- Start
- 2026-06-22
- Primary completion
- 2027-11
- Completion
- 2028-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TQH3906 | Small molecule | 16 mg | Oral |
| Subject | TQH3906 | Small molecule | 24 mg | Oral |